Saikawa A, Nomura T, Yamashita F, Takakura Y, Sezaki H, Hashida M
Department of Drug Delivery Research, Faculty of Pharmaceutical Sciences, Kyoto University, Japan.
Pharm Res. 1996 Oct;13(10):1438-44. doi: 10.1023/a:1016054807555.
The purpose of this study was to establish an experimental system for evaluation of the intratumoral behavior of drugs after intratumoral injection using perfused tissue-isolated tumor preparations of Walker 256 carcinoma (3.46-9.73g, n = 16).
We quantified the recovery of Phenol Red (model drug) in the tumor, leakage from the tumor surface and the venous outflow after intratumoral injection using perfused tissue-isolated tumors, and analyzed venous appearance curves based on a pharmacokinetic model in which the tumor tissue was assumed to be divided into two compartments, i.e., well- and poorly-perfused regions.
In small tumors (Type 1, 5.42 +/- 0.39 g), the drug appeared immediately in the venous outflow, and the amount remaining in the tumor tissue at 2 hr after injection was small. In contrast the venous appearance rate reached a significantly lower peak a few minutes after injection, and a large amount of injected drug remained in some large tumors (Type 2.8.17 +/- 0.51 g). Pharmacokinetic analysis revealed that there was a correlation between tumor weight and the rate constants of transfer from the poorly-perfused region to the well-perfused region, and between the rate constants of transfer from the well-perfused region to the venous outflow and dosing ratios into the well-perfused region.
An experimental system and analytical method were established for the evaluation of the intratumoral behavior of drugs after intratumoral injection using a tissue-isolated tumor perfusion system. This experimental system will be useful in analyzing the antitumor drug disposition after intratumoral injection.
本研究旨在建立一个实验系统,用于评估使用Walker 256癌的灌注组织分离肿瘤制剂(3.46 - 9.73g,n = 16)进行瘤内注射后药物在肿瘤内的行为。
我们使用灌注组织分离肿瘤,对瘤内注射后肿瘤中酚红(模型药物)的回收率、从肿瘤表面的渗漏以及静脉流出情况进行了定量,并基于一个药代动力学模型分析静脉出现曲线,该模型假定肿瘤组织分为两个部分,即灌注良好和灌注不良区域。
在小肿瘤(1型,5.42±0.39g)中,药物立即出现在静脉流出中,注射后2小时留在肿瘤组织中的量很少。相比之下,在一些大肿瘤(2型,8.17±0.51g)中,静脉出现率在注射后几分钟达到显著较低的峰值,并且大量注射药物仍留在肿瘤中。药代动力学分析表明,肿瘤重量与从灌注不良区域向灌注良好区域的转移速率常数之间,以及从灌注良好区域向静脉流出的转移速率常数与向灌注良好区域的给药比率之间存在相关性。
建立了一个实验系统和分析方法,用于使用组织分离肿瘤灌注系统评估瘤内注射后药物在肿瘤内的行为。该实验系统将有助于分析瘤内注射后抗肿瘤药物的处置情况。